Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children

Pediatric Infectious Disease Journal

Volumn 22, Issue 4, 2003, Pages 374-377

  Basualdo, Wilma ^a   Arbo, Antonio ^a,b  

^a UNIVERSIDAD NACIONAL DE ASUNCIÓN   (Paraguay)

^b Universidade Nacional de Asuncion ^*  (Paraguay)

Author keywords

Azithromycin; Cefixime; Shigella

Indexed keywords

AZITHROMYCIN; CEFIXIME;

ARTICLE; BACTERIUM ISOLATION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; ERADICATION THERAPY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHIGELLOSIS; TREATMENT OUTCOME;

AZITHROMYCIN; CEFIXIME; CHI-SQUARE DISTRIBUTION; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DYSENTERY, BACILLARY; FECES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PARAGUAY; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SHIGELLA; TREATMENT OUTCOME;

EID: 0037395748     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200304000-00019     Document Type: Article

References (22)

1. Prado V, O'Ryan M. Acute gastroenteritis in Latin America. Infect Dis Clin North Am 1994;8:77-106.
2. Basualdo W, Arbo A, Vega de Rojas G, et al. Etiología bacteriana de la diarrea aguda en niños menores de 2 años. Pediatría (Paraguay) 1996;23:50.
3. Guerrant R, Van Gilder T, Steiner T, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-50.
4. Keush GT, Bennish ML. Shigellosis. In: Evans AS, Brachman PS, eds. Bacterial infections of humans: epidemiology and control. New York: Plenum, 1991:593-620.
5. Guzmán-Blanco M, Casellas JM, Sader SH. Bacterial resistance to antimicrobial agents in Latin America: the giant is awakening. Infect Dis Clin North Am 2000;14:67-81.
6. Yadón Z, Schmunis G. Sensitivity of Salmonella, Shigella, and Vibrio cholerae to antimicrobials in the Americas, 1948 to 1998. In: Salvatierra-González R, Benguigui Y, eds. Antimicrobial resistance in the Americas: magnitude and containment of the problem. PAHO/HCP/HCT/163/2000:22-36.
7. Basualdo W, Campos A, Arbo A. High frequency of multiple antibiotic resistance of Shigella strains isolated from children with diarrhea in Paraguay [Abstract E-37]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
8. Basualdo W, Arbo-Sosa A. Monitoring of antibiotic resistance in Paraguay. In: Salvatierra-González R, Benguigui Y. Antimicrobial resistance in the Americas: magnitude and containment of the problem. PAHO/HCP/HCT/163/2000:154-8.
9. Salam MA, Bennish ML. Therapy for shigellosis: I. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 1988;113:901-7.
10. Abdus Salam M, Dhar U, Ali Khan W, Bennish ML. Randomized comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Lancet 1998;352:522-7.
11. Gordillo M, Singh K, Murria B. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother 1993;37:1203-5.
12. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
13. Foulds G, Shepard RM, Allen RH, Ferraina RA. Transintestinal elimination of azithromycin in dogs [Abstract 220]. In: Proceedings of the Fifth European Congress of Clinical Microbiology and Infectious Diseases, Oslo, 1991.
14. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin: a double-blind, randomized, controlled trial. Ann Intern Med 1997;126:697-703.
15. Ashkenazi S, Amir J, Waisman Y, et al. A randomized, double-blind study comparing cefixime and trimethoprim-sulfamethoxazole in the treatment of childhood shigellosis. J Pediatr 1993;123:817-21.
16. Salam MA, Seas C, Khan WA, Bennish ML. Treatment of shigellosis: IV. Cefixime is ineffective in shigellosis in adults. Ann Intern Med 1995;123:505-8.
17. American Academy of Pediatrics. Shigella infections. In: Pickering LK, ed. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2000:510-2.
18. National Committee for Clinical Laboratory Standards. Perfomance standards for antimicrobial disk susceptibility test. Approved Standard, M2-A6. 6th ed. vol 17. No. 1. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997.
19. Basualdo W, Laconich M, Campos A, Arbo-Sosa A. Susceptibilidad in vitro de azitromicina frente a cepas de Shigella sp. provenientes de nifios con diarrea disentérica. J Pediatr (Brazil) 1999;75:C19-22.
20. Young MJ, Bresnitz EA, Strom BL. Sample size nomograms for interpreting negative clinical studies. Ann Intern Med 1983;99:248-51.
21. Nelson JD, Kusmiesz H, Jackson LH. Comparison of trimethoprim-sulfamethoxazole and ampicillin therapy for shigellosis in ambulatory patients. J Pediatr 1976;89:491-3.
22. Nelson JD, Haltalin KC. In vitro effectiveness of four cephalosporins against shigellae and clinical ineffectiveness of cephaloglycin. Chemotherapy 1972;17:40-50.